Dr. Graham Wood has been appointed executive vice president, Phase I Clinical Development, Algorithme Pharma, part of the Altasciences Group. Dr. Wood will be involved in all aspects of Phase I trials.      Dr. Wood has worked in clinical pharmacology and has managed new molecular entities from toxicology to Phase IIa, as well as first-in-human to Phase IIa and conducted more than 200 clinical pharmacology studies. He has held senior level positions with several leading CROs, where he consulte...